Hepatitis C more prevalent than HIV/AIDS or Ebola, yet lacks equal attention

News Archive February 05, 2015

Hepatitis C more prevalent than HIV/AIDS or Ebola, yet lacks equal attention

Loyola researchers take lead in raising awareness
MAYWOOD, Ill. – More than 180 million people in the world have hepatitis C, compared with the 34 million with HIV/AIDS and the roughly 30,000 who have had Ebola. Yet very little is heard about the hepatitis C virus (HCV) in the way of awareness campaigns, research funding or celebrity fundraisers.

One of the global regions highly affected by hepatitis C is West Africa. In developed countries, hepatitis C, a blood-borne disease, is transmitted through intravenous (IV) drug use.

“In West Africa, we believe that there are many transmission modes and they are not through IV drug use, but through cultural and every day practices,” says Jennifer Layden, MD, PhD, principal investigator on a study recently published in the journal Clinical Infectious Diseases. “In this study, tribal scarring, home birthing and traditional as opposed to hospital based circumcision procedures, were associated with  hepatitis C infection in Ghana.”

The study was conducted by HepNet, an international multidisciplinary group of physicians and scientists “The other important finding was that a high percentage of individuals who tested positive for HCV had evidence of active infection,” says Dr. Layden. “This illustrates the need for treatment.”

Discovering the source of the disease and a target population, she says, will aid in the next step of the research: how to protect individuals and prevent the disease in Ghana.

Dr. Layden and colleagues from Loyola University Chicago’s Department of Public Health Sciences organized the inaugural HepNet meeting Aug. 12 and 13, 2013, in Kumasi, Ghana. Loyola is the lead investigator in the HepNet research, with collaboration from the Komfo Anokye Teaching Hospital in Ghana, the Centers for Disease Control and The Johns Hopkins University. This is the first published research study from the HepNet group.

“This is a small study conducted at a blood bank in a teaching hospital in Ghana,” says Dr. Layden. “We have now expanded studies to test more than 5,000 individuals in Ghana.”  The goal is to further understand who is affected by hepatitis C and to identify specific next steps in intervention and prevention.

“Hep C is a chronic disease and leads to chronic liver disease,  liver cancer and cirrhosis,” says Dr. Layden. “Overall, worldwide rates of liver cancer are on the rise, whereas many other cancers are on the decline or steady.” Layden says the study offers hope for West Africa.

Similar studies have been conducted in Egypt, a country with high rates of hepatitis C infection.

“Those studies helped to call attention to the widespread infection rate and resulted in getting infected Egyptians affordable medical treatment,” says Dr. Layden. “We in HepNet hope our studies will do the same in Ghana and other West African countries.”

Participating researchers from Loyola’s Stritch School of Medicine are Dr. Layden; Stephanie Kliethermes, PhD; Nallely Mora, MD; Lara Dugas, PhD; Amy Luke, PhD; David Shoham, PhD and Richard S. Cooper, MD.

]]>
The Loyola University Chicago Health Sciences Division (HSD) advances interprofessional, multidisciplinary, and transformative education and research while promoting service to others through stewardship of scientific knowledge and preparation of tomorrow's leaders. The HSD is located on the Health Sciences Campus in Maywood, Illinois. It includes the Marcella Niehoff School of Nursing, the Stritch School of Medicine, the biomedical research programs of the Graduate School, and several other institutes and centers encouraging new research and interprofessional education opportunities across all of Loyola University Chicago. The faculty and staff of the HSD bring a wealth of knowledge, experience, and a strong commitment to seeing that Loyola's health sciences continue to excel and exceed the standard for academic and research excellence. For more on the HSD, visit LUC.edu/hsd.
© 2011 Loyola University Chicago Health Sciences Division. All rights reserved.  &npsp; Privacy Policy   Privacy Policy